The full Guideline for oxygen use in adults in healthcare and emergency settings, published in Thorax 1 provides an update to the 2008 BTS Emergency oxygen guideline. 2 The following is a summary of the recommendations and good practice points. The sections noted to within this summary refer to the full guideline sections.
EXECUTIVE SUMMARY
Philosophy of the guideline ✓ Oxygen is a treatment for hypoxaemia, not breathlessness. Oxygen has not been proven to have any consistent effect on the sensation of breathlessness in nonhypoxaemic patients. ✓ The essence of this guideline can be summarised simply as a requirement for oxygen to be prescribed according to a target saturation range and for those who administer oxygen therapy to monitor the patient and keep within the target saturation range. ✓ The guideline recommends aiming to achieve normal or near-normal oxygen saturation for all acutely ill patients apart from those at risk of hypercapnic respiratory failure or those receiving terminal palliative care. 1. Assessing patients ○ For critically ill patients, high concentration oxygen should be administered immediately (table 1 and figure 1 ) and this should be recorded afterwards in the patient's health record. ○ Clinicians must bear in mind that supplemental oxygen is given to improve oxygenation, but it does not treat the underlying causes of hypoxaemia which must be diagnosed and treated as a matter of urgency. ○ The oxygen saturation should be checked by pulse oximetry in all breathless and acutely ill patients, 'the fifth vital sign' (supplemented by blood gases when necessary), and the inspired oxygen concentration should be recorded on the observation chart with the oximetry result. (The other vital signs are pulse rate, blood pressure, temperature and respiratory rate). ○ Pulse oximetry must be available in all locations where emergency oxygen is used. Clinical assessment is recommended if the saturation falls by ≥3% or below the target range for the patient. ○ All critically ill patients outside of a critical care area (e.g. intensive care unit (ICU), high dependency unit (HDU), respiratory HDU), should be assessed and monitored using a recognised physiological track and trigger system such as the National Early Warning Score (NEWS).
Target Oxygen prescription
○ Oxygen should be prescribed to achieve a target saturation of 94-98% for most acutely ill patients or 88-92% or patient-specific target range for those at risk of hypercapnic respiratory failure (tables 1-4). ○ Best practice is to prescribe a target range for all hospital patients at the time of admission so that appropriate oxygen therapy can be started in the event of unexpected clinical deterioration with hypoxaemia and also to ensure that the oximetry section of the early warning score (EWS) can be scored appropriately. ○ The target saturation should be written (or ringed) on the drug chart or entered in an electronic prescribing system (guidance on figure 1 ).
Oxygen administration
○ Oxygen should be administered by staff who are trained in oxygen administration.
○ These staff should use appropriate devices and flow rates in order to achieve the target saturation range (figure 2). ○ Staff should be trained in the use of a range of different oxygen delivery devices to ensure oxygen is delivered safely. 4. Monitoring and maintenance of target saturation ○ Oxygen saturation and delivery system (including flow rate) should be recorded on the patient's monitoring chart. ○ Oxygen delivery devices and flow rates should be adjusted to keep the oxygen saturation in the target range. Prompt clinical assessment is required if oxygen therapy needs to be initiated or increased due to a falling saturation level. ○ Oxygen should be prescribed and a signature should be entered on the drug chart on each drug round. 5. Weaning and discontinuation of oxygen therapy ○ Oxygen should be reduced in stable patients with satisfactory oxygen saturation. ○ Oxygen should be discontinued once the patient can maintain saturation within or above the target range breathing air but the prescription for a target range should be left in place in case of future deterioration and to guide early warning scores (EWS/NEWS).
KEY CHANGES SINCE THE FIRST EDITION OF THIS GUIDELINE PUBLISHED IN 2008 Methodology
The evidence review methodology has changed from NICE methodology to the BTS NICE accredited guideline production process which is based on the Scottish Intercollegiate Guideline Network (SIGN) methodology and adheres to AGREE methodology (see section 1).
Evidence levels and grade of recommendation These are now in SIGN format (see section 1 and tables 6 and 7).
Evidence base
The evidence base for the guideline has been updated to August 2013 (and extended to mid-2016 for key references). None of the 2008 recommendations have been challenged by new evidence, but many of the existing recommendations are supported by new information. There have been many observational studies but few randomised trials directly relevant to the guideline since 2008.
The remit of the guideline has been extended
The new guideline covers not just emergency oxygen use but most oxygen use in healthcare settings. It also covers short-term oxygen use by healthcare workers Table 1 Critical illnesses requiring high levels of supplemental oxygen (section 8.10)
The initial oxygen therapy is a reservoir mask at 15 l/min pending the availability of reliable oximetry readings. For patients with spontaneous circulation and a reliable oximetry reading, it may quickly become possible to reduce the oxygen dose whilst maintaining a target saturation range of 94-98%. If oximetry is unavailable, continue to use a reservoir mask until definitive treatment is available.
Patients with COPD and other risk factors for hypercapnia who develop critical illness should have the same initial target saturations as other critically ill patients pending the results of blood gas results after which these patients may need controlled oxygen therapy with target range 88-92% or supported ventilation if there is severe hypoxaemia and/or hypercapnia with respiratory acidosis.
Additional comments Recommendations
Cardiac arrest or resuscitation Refer to resuscitation guidelines for choice of delivery device during active resuscitation. Give highest possible inspired oxygen concentration during CPR until spontaneous circulation has been restored.
Recommendation E1
Shock, sepsis, major trauma, drowning, anaphylaxis, major pulmonary haemorrhage, status epilepticus Also give specific treatment for the underlying condition.
Recommendations E2-E4
Major head injury Early tracheal intubation and ventilation if comatose. Recommendation E5
Carbon monoxide poisoning Give as much oxygen as possible using a bag-valve mask or reservoir mask. Check carboxyhaemoglobin levels.
A normal or high oximetry reading should be disregarded because saturation monitors cannot differentiate between carboxyhaemoglobin and oxyhaemoglobin, owing to their similar absorbances. The blood gas PO 2 will also be normal in these cases (despite the presence of tissue hypoxia).
Recommendation E6
COPD, chronic obstructive pulmonary disease; CPR, cardiopulmonary resuscitation; PO 2 , oxygen tension blood gases. Figure 1 Oxygen prescription guidance for acutely hypoxaemic patients in hospital. COPD, chronic obstructive pulmonary disease; ICU, intensive care unit; NIV, non-invasive ventilation; PO 2 , oxygen tension; PCO 2 , arterial or arteriolised carbon dioxide tension; SpO 2 , arterial oxygen saturation measured by pulse oximetry.
outside of healthcare settings, but domiciliary oxygen use by patients is covered by the BTS Guideline for home oxygen use in adults.
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The scope of the guideline has been widened The present guideline includes the following new topics and settings which have been requested by guideline users:
• Postoperative and perioperative care including patient-controlled analgesia.
• Endoscopy and other procedures requiring conscious sedation.
• Palliative care settings including hospices.
• Use of helium-oxygen mixtures (Heliox) and nitrous oxide/oxygen mixtures (Entonox).
• Use of continuous positive airway pressure (CPAP).
• Use of oxygen by healthcare professionals in patients'
homes.
• Use of oxygen by voluntary rescue organisations and other non-National Health Service first responders.
• High flow nasal cannulae (HFNC).
The structure and format of the guideline has been changed since 2008 The 2008 Guideline was published as a self-contained document in Thorax.
1 Additional educational materials and other resources including audit tools were made available on the British Thoracic Society website. The new guideline exists in two complementary formats.
• A concise guideline which contains recommendations and good practice points is published here.
• The full guideline including evidence review, physiology overview, illustrations and references is published in Thorax 1 and is available on the British Thoracic Society website. The initial oxygen therapy is nasal cannulae at 2-6 L/min (preferably) or simple face mask at 5-10 L/min unless stated otherwise. For patients not at risk of hypercapnic respiratory failure who have saturation below 85%, treatment should be started with a reservoir mask at 15 L/min and the recommended initial oxygen saturation target range is 94-98%. If oximetry is not available, give oxygen as above until oximetry or blood gas results are available. Change to reservoir mask if the desired saturation range cannot be maintained with nasal cannulae or simple face mask (and ensure that the patient is assessed by senior medical staff). If these patients have coexisting COPD or other risk factors for hypercapnic respiratory failure, aim at a saturation of 88-92% pending blood gas results but adjust to 94-98% if the PCO 2 is normal (unless there is a history of previous hypercapnic respiratory failure requiring NIV or IMV) and recheck blood gases after 30-60 min, see 
INTRODUCTION Aim of the guideline
The key aim of this guideline is to make oxygen use in emergency and healthcare settings safer, simpler and more effective. Oxygen is probably the commonest drug used in the care of patients who present with medical emergencies. Prior to the publication of the first British Thoracic Society Guideline for Emergency Oxygen Use in Adult Patients in 2008, 1 ambulance teams and emergency department teams were likely to give oxygen to virtually all breathless or seriously ill patients and also to a large number of non-hypoxaemic patients with conditions such as ischaemic heart disease or stroke based on custom and practice. About 34% of UK ambulance journeys in 2007 involved oxygen use. 4 This translated to about two million instances of emergency oxygen use per annum by all UK ambulance services, with further use in patients' homes, GP surgeries and in hospitals. Audits of oxygen use and oxygen prescription have shown consistently poor performance in many countries, and most clinicians who deal with medical emergencies have encountered adverse incidents and occasional deaths due to underuse and overuse of oxygen. Acute and subacute neurological and muscular conditions producing muscle weakness These patients may require ventilatory support and they need careful monitoring which includes spirometry. If the patient's oxygen level falls below the target saturation, they need urgent blood gas measurements and are likely to need ventilatory support.
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Recommendation G4
Pregnancy and obstetric emergencies Oxygen therapy may be harmful to the fetus if the mother is not hypoxaemic.
Recommendations
H1-H4
Historically, oxygen has been administered for three main indications of which only one is evidence-based. First, oxygen is given to correct hypoxaemia because severe hypoxaemia is clearly harmful to the human body. Second, oxygen has been administered to ill patients in case they might become hypoxaemic. Recent evidence suggests that, if impaired gas exchange does actually develop, this practice may actually place patients at increased risk (see full Guideline section 6.3). Third, a very high proportion of medical oxygen was administered because most clinicians believed, prior to 2008, that oxygen can alleviate breathlessness in most circumstances. However, there is no good evidence that oxygen relieves breathlessness in non-hypoxaemic patients. There is evidence of lack of effectiveness or minimal effectiveness in mildly hypoxaemic breathless patients with chronic obstructive pulmonary disease (COPD) and advanced cancer (see full Guideline sections 6 and 8.11.4).
Against this background, the Standards of Care Committee of the British Thoracic Society (BTS) established a working party in association with 21 other societies to produce an evidence-based guideline for emergency oxygen use in the UK. This led to the production of the 2008 BTS Guideline for emergency oxygen use in adult patients which was the world's first guideline for emergency oxygen therapy. 1 This guideline has been implemented throughout the UK and in many other countries leading to over 500 citations in the medical literature up to the end of 2016.
The purpose of the update to the 2008 guideline is to strengthen the evidence base of the previous guideline based on revised methodology (which meets criteria contained in the AGREE II Instrument) and to extend the evidence base to the end of 2013. 12 Additionally, the remit of the 2008 Guideline has been broadened to cover several new aspects of oxygen use and a broader range of locations where oxygen might be used. Figure 2 Flow chart for oxygen administration on general wards in hospitals. COPD, chronic obstructive pulmonary disease. EPR, electronic patient record; EWS, early warning score; NEWS, National Early Warning Score; SpO2, arterial oxygen saturation measured by pulse oximetry.
Intended users of the guideline and target patient populations This guideline is mainly intended for use by all healthcare professionals who may be involved in emergency oxygen use. This will include ambulance staff, first responders, paramedics, doctors, nurses, midwives, physiotherapists, pharmacists and all other healthcare professionals who may deal with ill or breathless patients. Advice is also provided for first responders belonging to voluntary organisations or other non-NHS bodies. Information based on this guideline is available on the BTS website for use in the following situations:
• Hospital use.
• Primary care use.
• Ambulance use (supplemented by Ambulance service guidance based on this guideline).
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• Use by nursing staff and allied health professions. These abbreviated versions of the guideline contain the key recommendations and tables and charts that are relevant to the particular situation.
Areas covered by this guideline
The guideline addresses the use of oxygen in three main categories of adult patients in the prehospital and hospital setting and in other settings such as palliative care:
• Critically ill or hypoxaemic patients.
• Hypoxaemic patients and patients at risk of hypoxaemia.
• Non-hypoxaemic patients who may benefit from oxygen (eg, carbon monoxide poisoning).
Areas not covered by this guideline • Oxygen use in paediatrics: the present guideline applies only to patients aged >16 years.
• Oxygen use for high altitude activities.
• Oxygen use during air travel.
• Underwater diving and diving accidents.
• Oxygen use in animal experiments.
• Oxygen use in high-dependency units.
• Oxygen use in intensive care units.
• Interhospital level 3 transfers.
• Hyperbaric oxygen.
• Respiratory support techniques including tracheal intubation, invasive ventilation and non-invasive ventilation (NIV) (CPAP is included).
• Self-initiated use of oxygen by patients who have home oxygen for any reason.
• Ongoing care of hypoxaemic patients at home. 
SIGN levels of evidence
1++ High-quality meta-analyses, systematic reviews of RCTs or RCTs with a very low risk of bias 1+ Well-conducted meta-analyses, systematic reviews or RCTs with a low risk of bias 1 Meta-analyses, systematic reviews or RCTs with a high risk of bias 2++ High-quality systematic reviews of case-control or cohort studies High-quality case-control or cohort studies with a very low risk of confounding or bias and a high probability that the relationship is causal 2+ Well-conducted case-control or cohort studies with a low risk of confounding or bias and a moderate probability that the relationship is causal 2− Case-control or cohort studies with a high risk of confounding or bias and a significant risk that the relationship is not causal 3
Non-analytic studies, eg, case reports, case series 4
Expert opinion RCT, randomised controlled trial.
Table 7 SIGN grades of recommendation
Grades of recommendations
A At least one meta-analysis, systematic review or RCT rated as 1++, and directly applicable to the target population; or A body of evidence consisting principally of studies rated as 1+, directly applicable to the target population, and demonstrating overall consistency of results B A body of evidence including studies rated as 2++, directly applicable to the target population, and demonstrating overall consistency of results; or Extrapolated evidence from studies rated as 1++ or 1+ C A body of evidence including studies rated as 2+, directly applicable to the target population and demonstrating overall consistency of results; or Extrapolated evidence from studies rated as 2++ D Evidence level 3 or 4; or Extrapolated evidence from studies rated as 2+ Good practice points ✓ Recommended best practice based on the clinical experience of the guideline development group
Limitations of the guideline This guideline is based on the best available evidence concerning oxygen therapy. However, a guideline can never be a substitute for clinical judgement in individual cases. There may be cases where it is appropriate for clinicians to act outwith the advice contained in this guideline because of the needs of individual patients, especially those with complex or interacting disease states. Furthermore, the responsibility for the care of individual patients rests with the clinician in charge of the patient's care and the advice offered in this guideline must, of necessity, be of a general nature and should not be relied on as the only source of advice in the treatment of individual patients. In particular, this guideline gives very little advice about the management of the many medical conditions that may cause hypoxaemia (apart from the specific issue of managing the patients' hypoxaemia). Readers are referred to other guidelines for advice on the management of specific conditions such as COPD, pneumonia, heart failure etc. Some of these disease-specific guidelines may suggest slightly different approaches to emergency oxygen therapy whereas the present guideline aims to provide simple all-embracing advice about oxygen therapy.
Definitions of terms used in the guideline (and normal values)
Terms such as hypoxaemia and normal values for oxygen and carbon dioxide in blood gases are provided in the full Guideline (sections 3-6).
Planned review and updating of the guideline
The 2017 guideline will be reviewed by BTS within 5 years from publication.
Declarations of interest
All members of the Guideline Group made declarations of interest in line with the BTS Policy, and further details can be obtained on request from BTS.
SUMMARY OF GUIDELINE RECOMMENDATIONS AND GOOD PRACTICE POINTS
A. Achieving desirable oxygen saturation ranges in acute illness (see figures 1-2 and full Guideline sections 6 and 8) A1. This guideline recommends aiming to achieve a normal or near-normal oxygen saturation for all acutely ill patients apart from those at risk of hypercapnic respiratory failure (grade D). A2. The recommended target saturation range for acutely ill patients not at risk of hypercapnic respiratory failure is 94-98% (grade D). A3. For most patients with known COPD or other known risk factors for hypercapnic respiratory failure (eg, morbid obesity, cystic fibrosis, chest wall deformities or neuromuscular disorders, or fixed airflow obstruction associated with bronchiectasis), a target saturation range of 88-92% is suggested pending the availability of blood gas results (grade A for COPD, grade D for other conditions). A4. Most non-hypoxaemic breathless patients do not benefit from oxygen therapy, but a sudden reduction of ≥3% in a patient's oxygen saturation within the target saturation range should prompt fuller assessment of the patient (and the oximeter signal) because this may be the first evidence of an acute illness (grade D). A5 Since oxygenation is reduced in the supine position, fully conscious hypoxaemic patients should ideally be allowed to maintain the most upright posture possible (or the most comfortable posture for the patient) unless there are good reasons to immobilise the patient (eg, skeletal or spinal trauma) (grade D). B. Clinical and laboratory assessment of hypoxaemia and hypercapnia (see full Guideline section 7) B1 Fully trained clinicians should assess all acutely ill patients by measuring respiratory rate, pulse rate, blood pressure, temperature and assessing circulating blood volume and anaemia. Expert assistance from specialists in intensive care or from other disciplines should be sought at an early stage if patients are thought to have major lifethreatening illnesses and clinicians should be prepared to call for assistance when necessary including a call for a 999 ambulance in prehospital care or a call for the resuscitation team or intensive care unit (ICU) outreach team in hospital care (grade D). B2. Oxygen saturation, 'the fifth vital sign', should be checked by trained staff using pulse oximetry in all breathless and acutely ill patients (supplemented by blood gases when necessary) and the inspired oxygen device and flow rate should be recorded on the observation chart with the oximetry result (grade D). B3. Initial clinical assessment and subsequent monitoring of acutely unwell patients should include the use of a recognised physiological 'track and trigger' system, such as the NEWS which may trigger clinical review due to hypoxaemia, need for supplementary oxygen or for other reasons (grade D). B4. For patients who are at risk of hypercapnic respiratory failure, it is recommended that the relevant section of the 2017 NEWS chart should be used. Points are awarded if the oxygen saturation is below or above the target range (grade D). Good practice points for clinical assessment of patients with suspected hypoxaemia ✓ The medical history should be taken when possible in an acutely breathless patient and may point to the diagnosis of a particular acute illness such as pneumonia or pulmonary embolism or an exacerbation of a chronic condition such as COPD, asthma or heart failure. ✓ Never discontinue oxygen therapy to obtain an oximetry measurement on room air in patients who clearly require oxygen therapy.
✓ Physical examination should be undertaken urgently. This may provide evidence of a specific diagnosis such as heart failure or a large pleural effusion, but it is common for the cause of breathlessness to remain undiagnosed until the results of tests such as chest radiographs are available. ✓ Record arterial oxygen saturation measured by pulse oximetry (SpO 2 ) and consider blood gas assessment in patients with unexplained confusion and agitation as this may be presenting feature of hypoaxaemia and/or hypercapnia (cyanosis is a difficult physical sign to record confidently, especially in poor light or with an anaemic or plethoric patient). ✓ Carefully measure respiratory rate and heart rate because tachypnoea and tachycardia are more common than a physical finding of cyanosis in hypoxaemic patients. ✓ Appropriate changes should be made to any 'track and trigger' system used to allow for a lower target range in patients at risk of hypercapnic respiratory failure. These patients should score no points for saturation if within their target range and they should score points if the oxygen saturation falls below the target range or if the saturation rises above the target range while breathing oxygen. The 2017 update of the national NEWS chart has a special section for oximetry measurements for use with patients who have a target range 88-92% and it is recommended that the 2017 NEWS chart should be used in all hospitals (see recommendation B4). ✓ The presence of a normal SpO 2 does not negate the need for blood gas measurements especially if the patient is on supplemental oxygen therapy. Pulse oximetry will be normal in a patient with normal oxygen tension (PO 2 ) but abnormal blood pH or carbon dioxide tension PCO 2 or with a low blood oxygen content due to anaemia. For this reason, blood gases and full blood count tests are required as early as possible in all situations where these measurements may affect patient outcomes. ✓ All clinical staff who use oximeters must be trained in their use and made aware of the limitations of oximetry. (Oximetry is a valuable clinical tool but subject to artefact and errors of interpretation). C. Arterial and capillary blood gases (see full Guideline sections 7.1.3 and 8.4 and 8.5) C1. For critically ill patients or those with shock or hypotension (systolic blood pressure <90 mm Hg), the initial blood gas measurement should be obtained from an arterial sample. For most patients who require blood gas sampling, either arterial blood gases or arterialised earlobe blood gases may be used to obtain an accurate measure of pH and PCO 2 . However, the PO 2 is less accurate in earlobe blood gas samples (it underestimates the oxygen tension by 0.5-1 kPa) so oximetry should be monitored carefully if earlobe blood gas specimens are used and a repeat arterial specimen should be taken if there is any concern about the accuracy of a capillary sample (grade D D2. In other cases of acute hypoxaemia without critical illness or risk factors for hypercapnic respiratory failure, treatment should be started with nasal cannulae (or a simple face mask if cannulae are not tolerated or not effective) with the flow rate adjusted to achieve a saturation of 94-98% (grade D). D3. If medium-concentration therapy with nasal cannulae or a simple face mask does not achieve the desired saturation, change to a reservoir mask and seek senior or specialist advice (grade D). Good practice point ✓ High flow nasal oxygen using specialised equipment should be considered as an alternative to reservoir mask treatment in patients with acute respiratory failure without hypercapnia. For initial management of patients at risk of hypercapnic respiratory failure see recommendations G1 and G2. E. Oxygen therapy in critical illness (see table 1 and full Guideline section 8.10) E1. Use the highest feasible inspired oxygen for ventilation during cardiopulmonary resuscitation. Once spontaneous circulation has returned and arterial blood oxygen saturation can be monitored reliably, aim for a target saturation range of 94-98% and take an arterial blood gas sample to guide on-going oxygen therapy. If the blood gas shows hypercapnic respiratory failure, reset the target range to 88-92% or consider mechanical ventilation (grade D). E2. In critical illness, including major trauma, sepsis, shock and anaphylaxis, initiate treatment with a reservoir mask at 15 L/min and aim at a saturation range of 94-98%. This advice also applies to patients with critical illness who have risk factors for hypercapnia pending the results of blood gas measurements and expert assessment. In patients with spontaneous circulation and a reliable oximetry reading, it may be possible to maintain a saturation of 94-98% using lower concentrations of oxygen (grade D H. Oxygen use during pregnancy (see full Guideline section 8.14) H1. Women who suffer from major trauma, sepsis or acute illness during pregnancy should receive the same oxygen therapy as any other seriously ill patients, with a target oxygen saturation of 94-98%. The same target range should be applied to women with hypoxaemia due to acute complications of
Good practice points related to oxygen use in palliative care
Oxygen therapy for the symptomatic relief of breathlessness in palliative care patients is more complex than the simple correction of hypoxaemia. Consider the following issues: ✓ Consider early involvement of palliative care specialists and physiotherapists. ✓ As breathlessness is a multifactorial sensation-a comprehensive assessment of contributing factors (such as anxiety) should be carried out. ✓ Low-dose opioids should be considered because they are effective for the relief of breathlessness in palliative care patients. ✓ A trial of a handheld fan to help relieve breathlessness is recommended prior to trial of oxygen. ✓ Oxygen use has to be tailored to the individual and a formal assessment made of its efficacy for reducing breathlessness and improving quality of life for that person. ✓ Oxygen therapy should not be continued in the absence of patient benefit or where its disadvantages (eg, discomfort of masks or nasal cannulae, drying of mucous membranes) outweigh any likely symptomatic benefit.
L. Mixtures of oxygen with other gases (Heliox and Entonox)
Use of helium-oxygen mixtures (Heliox) (see full Guideline section 8. N2. CPAP with entrained oxygen to maintain saturation 94-98% should be considered to be an adjunctive treatment to improve gas exchange in patients with cardiogenic pulmonary oedema who are not responding to standard treatment in hospital care or in prehospital care (grade B). Good practice point, high-flow humidified nasal oxygen via nasal cannulae ✓ High flow nasal oxygen should be considered as a potentially superior alternative to reservoir mask treatment in patients with acute respiratory failure without hypercapnia.
ii P. Patients with tracheostomy or laryngectomy (see section 10.3) P1. When oxygen is required by patients with prior tracheostomy or laryngectomy, a tracheostomy mask (varying the flow as necessary) should achieve the desired oxygen saturation (tables 1-4 ). An alternative delivery device, usually a T-piece device fitted directly to the tracheostomy tube, may be necessary if the patient deteriorates (grade D). Q. Humidification of oxygen (see section 10.2) Q1. Humidification is not required for the delivery of low-flow oxygen (mask or nasal cannulae) or for the short-term use of high-flow oxygen. It is not therefore required in prehospital care. Pending the results of clinical trials, it is reasonable to use humidified oxygen for patients who require high-flow oxygen systems for more than 24 hours or who report upper airway discomfort due to dryness (grade D). Q2. In the emergency situation, humidified oxygen use can be confined to patients with tracheostomy or an artificial airway although these patients can be managed without humidification for short periods of time (eg, ambulance journeys) (grade D). Q3. Humidification may also be of benefit to patients with viscous secretions causing difficulty with expectoration. This benefit can be achieved using nebulised normal saline (grade D). Q4. Bubble bottles which allow a stream of oxygen to bubble through a container of water should not be used because there is no evidence of a clinically significant benefit but there is a risk of infection (grade D). Good practice points related to humidified oxygen therapy ✓ Consider use of a large volume oxygen humidifier device for patients requiring high-flow rates or longer term oxygen, especially if sputum retention is a clinical problem. ✓ In the absence of an artificial airway, the decision to humidify supplemental oxygen needs to be made on an individual basis but this practice is not evidence-based. R. Driving gas for nebulised treatments (see section 10.4) R1. For patients with asthma, nebulisers should be driven by piped oxygen or from an oxygen cylinder
ii The prefix O is not in use for recommendations.
fitted with a high-flow regulator capable of delivering a flow rate of >6 L/min. The patient should be changed back to his/her usual oxygen mask or cannulae when nebuliser therapy is complete. If the cylinder does not produce this flow rate, an airdriven nebuliser (with electrical compressor) should be used with supplemental oxygen by nasal cannulae at 2-6 L/min to maintain an appropriate oxygen saturation level (grade D). R2. When nebulised bronchodilators are given to patients with hypercapnic acidosis, they should be given using an ultrasonic nebuliser or else a jet nebuliser driven by compressed air and, if necessary, supplementary oxygen should be given concurrently by nasal cannulae to maintain an oxygen saturation of 88-92%. The same precautions should be applied to patients who are at risk of hypercapnic respiratory failure prior to the availability of blood gas results and the oxygen saturation should be monitored continuously during treatment. Once the nebulised treatment is completed for patients at risk of hypercapnic respiratory failure, their previous targeted oxygen therapy should be reinstituted (grade D). Good practice points Do not allow hypoxaemia to occur while administering nebulised treatments. ✓ For hypoxaemic patients, oxygen therapy should continue during nebulised treatments. Driving gas for nebulised treatment in ambulances: ✓ During treatment by ambulance staff, oxygen-driven nebulisers should be used for patients with asthma and may be used for patients with COPD in the absence of an air-driven compressor system. If oxygen is used for patients with known COPD, its use should be limited to 6 min. This will deliver most of the nebulised drug dose but limit the risk of hypercapnic respiratory failure (section 10.4). Ambulance services are encouraged to explore the feasibility of introducing battery powered, air-driven nebulisers or portable ultrasonic nebulisers. S. Prescribing oxygen therapy (see full Guideline section 11) S1. Every healthcare facility should have a standard oxygen prescription document or, preferably, a designated oxygen section on all drug prescribing cards or guided prescription of oxygen in electronic prescribing systems (grade D). S2. A prescription for oxygen should always be provided, except in sudden illness when it must be started immediately and documented retrospectively (grade D). S3. Doctors and other prescribers should prescribe oxygen using a target saturation range (sections 8, 9 and 11) and sign the drug chart or electronic prescribing order (grade D). S4. An oxygen target saturation range should be prescribed for all patients who are admitted to hospital. This will ensure that every patient will receive appropriate oxygen therapy if it should be required. It will also ensure that all clinicians are aware of the appropriate oxygen target range for every patient under their care (grade D). Good practice points related to prescribing and administering oxygen therapy to patients ✓ Oxygen should be prescribed on the drug chart or electronic prescribing system using a target saturation range. ✓ Oxygen should be prescribed to a target saturation range rather than prescribing a fixed concentration of oxygen or fraction of inspired oxygen (see recommendations A1, A2, A4 and A5) ✓ In most emergency situations, oxygen is given to patients immediately without a formal prescription.
The lack of a prescription should never preclude oxygen being given when needed in an emergency situation. However, a subsequent written record must be made of what oxygen therapy has been given to every patient in a similar manner to the recording of all other emergency treatment. ✓ If a patient has an oxygen alert card, initial oxygen therapy should be based on the guidance on the card until the results of blood gases are available. T. Monitoring and adjusting oxygen therapy (see full Guideline sections 9-11) T1. Pulse oximetry must be available in all locations where emergency oxygen is being used by healthcare professionals (see also the limitations of using pulse oximetry section 7.1.2) (grade D). T2. All documents which record oximetry measurements or blood gas results should state whether the patient is breathing air or a specified oxygen delivery device and flow rate using the abbreviations shown in table 5 (grade D). T3. In all situations where repeated blood gas measurements are required, they should be measured as soon as possible, usually within 30 min of any treatment change, to determine if the proposed target saturations are appropriate. Consider the use of an indwelling arterial catheter if multiple samples are likely to be required (grade D). T4. Adjustments should only be made by registered staff who have been trained to administer oxygen. If the oxygen saturation falls below the prespecified range, the concentration of oxygen should be increased; if the saturation rises above this range, the oxygen concentration should be reduced. If the monitoring of oxygen saturation is performed by unregistered staff (eg, healthcare assistants), there must be a clear protocol in place which requires that they should inform staff who are trained to administer oxygen if the oxygen saturation is above or below the target saturation (grade D). Good practice points related to administration of oxygen therapy ✓ For hypoxaemic patients, oxygen therapy should continue during other treatments such as nebulised therapy. Clinicians should assess the clinical status of the patient prior to prescribing oxygen and the patient's condition should be reassessed frequently during oxygen use (see recommendations B1-B3).
✓ The administering healthcare professional should note the oxygen saturation before starting oxygen therapy wherever possible but never discontinue or delay oxygen therapy for seriously ill patients (see recommendation B2). ✓ The healthcare professional should start oxygen therapy using an appropriate delivery system and flow rate as specified in sections 8-10 of this guideline. The target oxygen saturation should be documented on the respiratory section of the observation chart. ✓ Whenever possible, patients should be given an oxygen information sheet (example in web appendix 6 on the BTS website). ✓ Staff should check the oxygen supply and connections on a regular basis because there have been serious incidents due to disconnection or misconnection of oxygen supplies. ✓ Staff must ensure that adequate oxygen is provided during transfers and while patients are in diagnostic departments. Additionally, oxygen saturation should be monitored continuously for seriously ill patients who require escorted transfers. This is because there have been serious incidents involving accidental discontinuation of oxygen or cylinders running out during interward transfers or transfers to other departments such as for X-rays. U. Weaning and discontinuation of oxygen therapy U1. Lower the oxygen concentration if the patient is clinically stable and the oxygen saturation is above the target range or if it has been in the upper zone of the target range for some time (usually 4-8 hours) (grade D). U2. If the target saturation is maintained, the new delivery system and flow should be continued. Repeat blood gas measurements are not required. If the patient is stable, the process can be repeated and the patient can eventually be weaned off oxygen (see section 12) (grade D). U3. Most stable convalescent patients will eventually be stepped down to 2 L/min via nasal cannulae prior to cessation of oxygen therapy. Patients at risk of hypercapnic respiratory failure may be stepped down to 1 L/min (or occasionally 0.5 L/min) via nasal cannulae or a 24% Venturi mask at 2 L/min as the lowest oxygen concentration prior to cessation of oxygen therapy (grade D). U4. Oxygen therapy should be stopped once a patient is clinically stable on low-concentration oxygen, and the oxygen saturation is within the desired range on two consecutive observations (but the prescription for a target saturation range should remain active in case of future deterioration). It may be appropriate to alter the target range following senior review in patients with chronic cardiopulmonary disease who either have saturations <94% when stable or in whom it is deemed sensible to discharge from hospital with saturations <94% pending an outpatient oxygen assessment. Oxygen should also be stopped if the patient has come to the end of a written protocol of timed oxygen (eg, postoperatively) (grade D who have had an episode of hypercapnic respiratory failure should be issued with an oxygen alert card and with a 24% or 28% Venturi mask. They should be instructed to show the card to the ambulance crew and emergency department staff in the event of an exacerbation. ✓ Oxygen alert cards with agreed content can be obtained via the BTS website. ✓ The content of the alert card should be specified by the physician in charge of the patient's care, based on previous blood gas results. ✓ The primary care team and ambulance service should also be informed by the hospital COPD team that the patient has had an episode of hypercapnic respiratory failure and carries an oxygen alert card. The home address and ideal oxygen concentration or target saturation ranges of these patients can be flagged in the ambulance control systems and information disseminated to ambulance crews when required. ✓ When possible, out-of-hours services providing emergency primary care services should be informed by the hospital COPD team or by the primary care team that the patient has had an episode of hypercapnic respiratory failure and carries an oxygen alert card. Use of oxygen in these patients will be guided by the instructions on the alert card or by a Patient Specific Protocol which can be shared by hospital teams, the ambulance service and the primary care team. W. Practical aspects of oxygen dispensing, documentation and monitoring W1. Registered nurses and others who dispense drugs in hospitals should sign the drug chart or electronic prescribing record at every drug round and check that the patient is receiving oxygen therapy. This is to check that the patient is within the target saturation and also to check whether weaning and discontinuation should be instituted (grade D). W2. Most patients are prescribed an oxygen target range. If patients are on air at the time of the drug round, registered nurses should sign the drug chart using a code such as 'A' for air and the observation chart should also be filled in using the code A for air (see table 5 and figure 19 in the full guideline) (grade D). W3. All patients should have their oxygen saturation observed for at least 5 min after starting oxygen therapy or for patients who require an increased concentration of oxygen and after oxygen therapy has been decreased or stopped (grade D). W4. If the oxygen saturation is above the target saturation range and the patient is stable, the delivery system or oxygen flow rate should be modified to return the saturation to within the target range (grade D). W5. Patients who have a target saturation of 88-92%
should have their blood gases measured within 30-60 min. This is to ensure that the carbon dioxide level is not rising. This recommendation also applies to those who are at risk of developing hypercapnic respiratory failure but who have a normal PCO 2 on the initial blood gas measurement (grade D). W6. Stable patients whose oxygen saturation is within their target saturation range of 94-98% do not need repeat blood gas measurements within 30-60 min if there is no risk of hypercapnic respiratory failure and acidosis and may not need any further blood gas measurements unless there should be further deterioration including symptoms or signs of possible hypercapnia (grade D). W7. Stable patients on oxygen treatment should have SpO 2 and physiological variables (eg, NEWS) measured four times a day (grade D). W8. In those who have signs of critical illness (eg, NEWS score 7 or above), oxygen saturation should be monitored continuously and the patient may require level 2 or level 3 care on a highdependency unit or critical care unit (grade D). W9. If the patient is clinically stable and the oxygen saturation is within the target range, treatment should be continued (or eventually lowered) depending on the clinical situation (grade D).
W10. Oxygen therapy should be increased if the saturation is below the desired range and decreased if the saturation is above the desired range (and eventually discontinued as the patient recovers) (grade D). W11. The new saturation (and the new delivery system) and flow rate should be recorded on the patient's observation chart after 5 min of treatment at the new oxygen concentration. Each change should be recorded by the clinician trained to administer oxygen by signing the observation chart (only changes should be signed for) (grade D). W12. Repeat blood gas measurements are not required for stable patients who require a reduced concentration of oxygen (or cessation of oxygen therapy) to maintain the desired target saturation (grade D). W13. Patients with no risk of hypercapnic respiratory failure do not always need repeat blood gas measurements after an increase in oxygen concentration. However, the patient requires clinical review to determine why the oxygen saturation has fallen (grade D). W14. Patients at risk of hypercapnic respiratory failure (usually those with a target range of 88-92%; see table 4) require repeat blood gas assessment 30-60 min after an increase in oxygen therapy (to ensure that the carbon dioxide level is not rising) (grade D). W15. For patients with no risk of hypercapnic respiratory failure, monitoring by pulse oximeter is sufficient (repeated blood gases not required) provided the patient is clinically stable and the oxygen saturation remains in the desired range, usually 94-98% (grade D). W16. If a patient's oxygen saturation is lower than the prescribed target range, first check all aspects of the oxygen delivery system and the oximeter device for faults or errors (grade D). W17. If a patient's oxygen saturation is consistently lower than the prescribed target range, there should be a medical review and the oxygen therapy should be increased according to an agreed written protocol (grade D). W18. If the oxygen saturation fails to rise following 5-10 min of increased oxygen therapy or if there is clinical concern following medical review, then blood gas measurements should be repeated (grade D). X. Training in oxygen prescribing and use X1. All clinicians prescribing oxygen should have appropriate training and access to written or electronic oxygen prescribing guidelines based on this national guideline (grade D) (see online appendices 7 and 8). X2. Every hospital should have a training programme to ensure that clinical staff are familiar with the hospital's oxygen administration policies. In view of the high number of adverse incidents related to oxygen therapy, it is recommended that all acute trusts should include basic training in oxygen use in the mandatory training programmes for all clinical staff (grade D).
Healthcare providers need to use clinical judgement, knowledge and expertise when deciding whether it is appropriate to apply recommendations for the management of patients. The recommendations cited here are a guide and may not be appropriate for use in all situations. The guidance provided does not override the responsibility of healthcare professionals to make decisions appropriate to the circumstances of each patient, in consultation with the patient and/or their guardian or carer.
